全球女性絕育器材市場－市場規模（按細分市場劃分）、佔有率、監管、報銷、幹預措施及預測（至2036年）

女性絕育是一種永久性幹預措施，透過手術和非手術方法阻斷輸卵管。隨著教育程度和收入的提高，未來大多數國家女性絕育器械的使用率可能會保持穩定（下降和成長速度都非常緩慢）。可逆避孕方法和男性絕育手術正變得越來越受歡迎。輸精管結紮術被認為比女性絕育更安全，因為即使手術失敗，它也不會增加子宮外孕的風險。然而，新型低成本技術和器械的出現，以及副作用極少或無副作用、可降低性傳染病風險的器械的出現，可能會顯著抑制輸卵管夾和環的市場，並在未來創造新的機會。女性絕育並不能有效預防性傳染病，包括愛滋病毒感染。由於這些方法是永久性的，因此建議那些決定未來不再生育的女性採用。

本報告調查並分析了全球女性絕育器材市場，提供了有關區域市場規模、主要趨勢、創新產品和技術以及競爭格局的資訊。

市場模型的關鍵組成部分包括：

已上市的女性絕育設備及不斷變化的競爭格局

• 關鍵產業趨勢探討
• 女性絕育設備市場各細分領域的年度收入和市場預測（2015-2036 年）
• 各細分領域的總幹預次數、單位銷售、平均售價和市場價值的詳細數據

全球、區域與國家層面各市場的探討

• 按地區劃分的定性市場訊息，涵蓋全球趨勢和各國市場分析
• 女性絕育設備市場的 SWOT 分析
• 女性絕育設備市場競爭動態與趨勢探討

全面了解市場，包括對醫療保健系統的概述，有助於更好地理解市場。此外， "市場准入" 部分還提供有關報銷政策和監管環境的信息，以便更深入地了解市場動態。

• 各國醫療保健系統概覽
• 報銷政策
• 醫療科技監管環境

目標公司

• 猶他醫療產品公司 (Utah Medical Products Inc)
• Gyrus ACMI 公司
• 其他

Female Sterilization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Reproductive Health Devices therapeutic area.

Female Sterilization is a permanent intervention where the fallopian tubes are blocked using surgical and non-surgical techniques. The fallopian tubes are blocked to prevent the sperm from fertilizing the egg, thereby preventing the woman from becoming pregnant.

Female sterilization is a permanent intervention where the fallopian tubes are blocked using surgical and non-surgical techniques. Use of female sterilization devices may remain stable (with very low rates of decline/increase) in future with greater educational attainment and income in most of the countries. Reversible methods and male sterilization are increasing in popularity; vasectomy is considered to be safer than female sterilization as there is no increased risk of ectopic pregnancy if vasectomy fails. However, introduction of new and low cost technologies/devices that reduce the risk of STD's, and cause no/less side effects may hinder the tubal clips/rings market to a large extent and may generate new opportunities in the future. Female sterilization does not protect against sexually transmitted diseases, including HIV. Since, these methods are permanent; these are recommended for women who are sure of their decision of not having any children in the future.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Female Sterilization Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Female Sterilization Devices market revenue by segment and market outlooks from 2015-2036.
• Granular data on total Interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Female Sterilization Devices market.
• Competitive dynamics insights and trends provided for Female Sterilization Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Utah Medical Products Inc, Gyrus ACMI Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Female Sterilization Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Female Sterilization Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Female Sterilization Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Female Sterilization Devices market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.